Council overruled on children's home plans
A move to open a children's home that was twice turned down will now go ahead after councillors in Wolverhampton were overruled by the government's planning inspector.
The City of Wolverhampton Council had rejected two planning applications to convert the residential property in Redhouse Road, Tettenhall into a children's home for up to three children.
Councillors had said there was "no demonstrable need" for the children's home.
However, the inspector questioned this, saying figures presented to the appeal suggested it was "not evident" that the supply of children's homes in the aera was meeting local need.
Planning applications to convert the home were rejected in April and December last year before applicant Ernest Mandaza of Professional Healthcare Solutions made an appeal to the government's planning inspector in a bid to get the decision overturned.
The inspector, who has the power to overrule the council, said figures provided during the appeal showed that 88 children in care were housed 20 miles or more away from the city at the end of 2023 - including more than a dozen that lived in homes further than 100 miles away.
"The council states that there is not a demonstrable need locally for this use, but I have limited substantiated evidence to support this point nor that the need for such accommodation would not increase in the near future," the inspector said.
"Whilst I note that there are several private children's care homes in the city as well as some in the nearby area, it is not evident that these, alongside the council's own provision, are meeting its need."
The inspector said that moving children more than 20 miles away from friends, family and schools could result in them having "significantly lower wellbeing" than at home.
The inspector also disagreed with several neighbours who said the children's home would "threaten their safety", saying the plan would result in "no significant harm" given the number of staff present for the three vulnerable children.
When rejecting the second application last year, City of Wolverhampton Council's planners said the level of support for three looked after children would be "considerably different" to that of a family home - leading to more noise and disturbance.
The decision read: "The application would result in the loss of another family dwelling... in this area, and the council's children's services have also confirmed that there is not a demonstrable need for such accommodation in the city of Wolverhampton and have also advised there are already a number of children's homes in close proximity to the application site."
This news was gathered by the Local Democracy Reporting Service which covers councils and other public service organisations.
Follow BBC Wolverhampton & Black Country on BBC Sounds, Facebook, X and Instagram.
City of Wolverhampton Council
Local Democracy Reporting Service
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fox News
an hour ago
- Fox News
Experimental cholesterol pill cuts heart attack risk with 'convenient' once-daily dose
A new daily pill could provide an easier, more convenient way to lower cholesterol and reduce heart attack and stroke risk. The experimental medication, called Obicetrapib, underwent a Phase 3 clinical trial at Monash University in Australia. The trial included more than 2,500 people averaging 65 years of age. All had either been diagnosed with heart disease or had genetically high cholesterol, according to a university press release. All participants were receiving "maximum tolerated doses" of cholesterol-lowering therapy. One group received Obicetrapib and another group took a placebo, while still maintaining their existing cholesterol drugs. After 12 weeks, the participants taking the new drug showed a 32.6% reduction in LDL cholesterol and a 33.5% drop in lipoprotein(a) [Lp(a)], the release stated. The findings were presented last month at the European Atherosclerosis Society Congress in the U.K. and were also published in The New England Journal of Medicine. "We know that many people at high risk of heart attack or stroke don't get their cholesterol levels low enough, even on the best available treatments," said study lead Professor Stephen Nicholls, director of Monash University's Victorian Heart Institute and Monash Health's Victorian Heart Hospital, in the release. "We know that many people at high risk of heart attack or stroke don't get their cholesterol levels low enough, even on the best available treatments." "Obicetrapib offers a promising new option — not only did it lower LDL cholesterol by over 30%, but we also saw a reduction in Lp(a), which is much harder to treat and has been linked to increased heart disease risk." Low-density lipoprotein (LDL), which is sometimes called "bad cholesterol," is associated with negative health effects when present in high amounts. LDL can build up in the blood vessels and increase heart attack and stroke risk, the researchers cautioned. Lipoprotein(a), or Lp(a), is a protein that is known to greatly increase the chances of a heart attack when it's present in high levels in the blood. Unlike LDL, Lp(a) is an inherited risk factor that can't be modified with healthy behaviors or medications. Obicetrapib was found to be "well-tolerated" by the participants, the researchers noted. "This could be a valuable tool in the fight against heart disease," Nicholls added. "It's convenient, it's effective, and it may help close the gap for patients who've run out of options." The study — which was funded by NewAmsterdam Pharma, a developer of Obicetrapib that is based in the Netherlands — did have some limitations, the researchers noted. For example, the participants were not chosen based on high Lp(a), which means the study did not determine how the drug impacted those with elevated levels of the protein. Additionally, the study assessed changes in LDL levels, but did not measure actual heart attack or stroke outcomes. For more Health articles, visit More studies are needed to follow patients for longer time periods and to include more diverse cohorts, the researchers acknowledged. Fox News Digital reached out to the researchers for additional comment.
Yahoo
3 hours ago
- Yahoo
Queen Camilla's ‘Health Issues' Revealed After King Charles' Cancer Found ‘Incurable'—She's on ‘Her Last Legs'
A lot of the conversation about the British Royal family in the last few years has been about the health of different members of the family. Sure, the feuds take a lot of the attention, but it's impossible to ignore that the health of various members of the royal family has been under scrutiny lately. This includes King Charles, who has cancer and is reportedly very sick, and Kate Middleton, who was diagnosed with cancer as well, and who is now cancer-free. Health speculation now includes Queen Camilla, too. The Queen is reportedly not doing very well, with a source telling RadarOnline, 'Camilla really is on her last legs – literally. Along with all her other health issues, she can now hardly walk.' More from StyleCaster Trump Accused of Stealing King Charles' Thunder After the Royal Made a Clear Stance Against the President Prince William Faces Devastating News After King Charles' Cancer Found 'Incurable' Related: See what Queen Camilla looked like throughout the years The source explained her issues in detail and what is being done to manage them. 'She gets these Sole Bliss shoes made by a company in London shipped into the palace by the truckload as she is trying to cover up her feet deformities on royal engagements. She has the shoes hand-tooled to cover up the bony looking growths on the sides of her feet and totters around in them trying to pretend like there's nothing wrong.' However, the source also added that 'sooner or later she could be headed for a wheelchair – if she lives much longer,' explaining that 'Her spending on medics and specialists is through the roof as she's too vain to admit she needs a wheelchair.' Reportedly, the Queen has been warned against painful surgery to remove bunions. The outlet also reports the Palace has hidden the Queen's ailments for a while, as she reportedly had to have surgery for a pickled liver due to her decades of drinking years ago. She also recently had pneumonia. However, it seems now the stress of her husband's illness and the desire not to appear crippled in public are putting great strain on her. All of this comes amid reports that King Charles' cancer is reportedly incurable, but manageable, according to royal writer and associate editor of the Daily Telegraph, Camilla Tominey. 'The talk now is that he may die 'with' cancer, but not 'of' cancer following a rigorous treatment program,' she wrote. Tominey also said that planning for Charles' 80th birthday in 2028, while 'very tentative,' is going ahead. Not just that, there are reportedly plans for King Charles and his son, Prince Harry, to reunite publicly at the Invictus Games in Birmingham in 2027. 'There is an awareness that the impasse cannot continue forever, not least if it starts to reflect badly on the king.' Prince Harry recently spoke of his desire to reconcile with his father, referencing his illness specifically, and indicating that he didn't know how long his father had left. The hope would be that the reunion would also include Prince Harry's kids. However, it looks like there are plenty of health concerns in the royal family, and right now, there's very little anyone can do but see how things develop. Best of StyleCaster The 26 Best Romantic Comedies to Watch if You Want to Know What Love Feels Like These 'Bachelor' Secrets & Rules Prove What Happens Behind the Scenes Is So Much Juicier BTS's 7 Members Were Discovered in the Most Unconventional Ways
Yahoo
5 hours ago
- Yahoo
Cornish charity boss completes month-long 5k-a-day challenge
A Cornish charity boss has completed a month-long challenge to walk or jog 5k every day. Claire Eldred, director at Dravet Syndrome UK, took part in the #EveryDayinMayForDravet challenge to help raise funds and awareness for the rare form of epilepsy. Dravet Syndrome is a severe neurological condition associated with epilepsy and learning disabilities, affecting one in 15,000 live births in the UK. Lucy Murphy, a young woman who has Dravet Syndrome, and Claire Eldred taking part in the challenge. (Image: supplied) Daily, those with Dravet often endure multiple seizures, and face a significantly higher risk of sudden unexpected death in epilepsy (SUDEP). Clare, who lives in Botallack, West Penwith, said: "I'm very proud to be doing #EveryDayinMayForDravet with and for all the families across the UK who are affected by this devastating, life limiting condition. "Sadly, it's all too common for individuals with Dravet Syndrome to have to wait months or even years to receive a diagnosis as sometimes even medics have not heard of Dravet. "I hope that raising awareness across Cornwall and the Southwest will lead to more families getting an earlier diagnosis and access to the treatment and support that they need." She also highlighted the importance of donations for the charity's continued work. Clare added: "As a small charity, all donations received make a huge difference in helping us to continue our vital work supporting and empowering families, educating professionals, and funding research. "A huge thank you to everyone who is sponsoring me or who is taking part or donating for #EveryDayinMayForDravet." The #EveryDayinMayForDravet challenge saw hundreds of participants across the globe, many of whom committed to 5k or 10k daily efforts. The challenge welcomed all ages and fitness levels, with some children participating in a 2k daily task. This family-friendly initiative is designed to not only raise funds but also to bolster community spirit and inclusivity among supporters. Dravet Syndrome UK continues to serve as a lighthouse for families who struggle with the complex challenges posed by Dravet Syndrome. They aim to ensure those affected receive timely diagnosis, treatment, and the essential support required for improved lives. To sponsor Claire or donate to the cause, visit the charity's JustGiving page. For more information, please visit Dravet Syndrome UK's website.
